| المستخلص: |
If people are exposed to large amounts of radiation during childhood or have received radiation therapy for medical issues in the head and neck area, they are at a higher risk of developing thyroid cancer, so this study is designed to help you and your family understand more about your radiation therapy. This study was conducted at the Department of Oncology and Endocrinology at Tripoli University Hospital (TUH), where 30 thyroid cancer patients were studied, and the data was collected using a patient record file. The highest incidence of papillary thyroid cancer in the age group (24-38) was 66.7%, goiter was 55.6% in the age group (66-80), medullary thyroid cancer had the highest incidence of 36.4%, while the lowest was 33.30% in the age group (52-66) (the lowest was 11%). 10% had follicular thyroid cancer in the age group (24-38), in the age group (80-66) and radioactive iodine was used as a high-risk treatment after thyroidectomy for residual or recurrent thyroid cancer, the highest percentage in three treatment sessions was (100%) for those receiving a dose of (80.6-104.6mci). This is because the tumor was large in size and could not be eliminated in one session, so he had to take three treatment sessions. As for the patients who took one treatment session, their percentage was (58.3%) for those who received a dose of (32.6i-56.6mci) and patients who took two treatment sessions, their percentage (50%) received a dose of (32.6i-56.6mci) and (56.6 -80.6mci). From this, we conclude that the overall proportion of people with thyroid cancer is higher in males than females. Objective of the study: 1-The study seeks to reach the primary objective of treating deep-seated thyroid tumors. 2-Destroy the genetic material (DNA) in cancer cells so that the cells lose their ability to reproduce and may die, and the tumor may gradually shrink. 3- Identify the types of radioactive iodine used in the diagnosis and treatment of cancerous tumors.
|
